Amedisys, Baton Rouge, La., announced it signed a definitive agreement to acquire Beacon Hospice, Boston, for $125 million.
Amedisys to acquire Beacon Hospice
Beacon operates 23 free-standing locations and one inpatient facility across Connecticut, Maine, Massachusetts, New Hampshire and Rhode Island. The deal is subject to customary closing conditions including regulatory approval, and the price is subject to customary adjustments, according to a news release from Amedisys.
"This acquisition aligns with our strategy of providing a continuum of at-home healthcare, of which hospice continues to be a significant area of focus both clinically and in terms of growth," Amedisys CEO William Borne said in the release. (Watch a November video interview with Borne discussing home health's role in promoting integrated care, reducing hospital readmissions and a pilot project in the Patient Protection and Affordable Care Act.)
In September, Amedisys announced that the U.S. Justice Department wanted the company to turn over clinical and business operation documents under a civil investigative demand linked to the federal False Claims Act.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.